• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

游离前列腺特异性抗原的双单克隆抗体免疫测定法。

Dual monoclonal antibody immunoassay for free prostate-specific antigen.

作者信息

Wang T J, Hill T M, Sokoloff R L, Frankenne F, Rittenhouse H G, Wolfert R L

机构信息

Department of Research and Development, Hybritech Incorporated, San Diego, CA 92196, USA.

出版信息

Prostate. 1996 Jan;28(1):10-6. doi: 10.1002/(SICI)1097-0045(199601)28:1<10::AID-PROS2>3.0.CO;2-S.

DOI:10.1002/(SICI)1097-0045(199601)28:1<10::AID-PROS2>3.0.CO;2-S
PMID:8545276
Abstract

Prostate-specific antigen (PSA) is the most important tumor marker for early detection and monitoring of prostate cancer (PCa) patients. PSA is also elevated in many patients with benign prostatic hyperplasia (BPH). The study of the serum PSA forms, free PSA (f-PSA) and PSA complexed with alpha 1-antichymotrypsin (PSA-ACT), may improve the discrimination between PCa and BPH. An immunoassay specific for f-PSA is reported with very low cross-reactivity (0.7%) to PSA-ACT. Serum specimens from BPH and PCa patients (determined by biopsy) with PSA levels from < 1 to > 100 ng/ml were tested. No f-PSA was detected in serum specimens from normal females (N = 50). Low levels (0-0.3 ng/ml) were detected in specimens from healthy males (N = 60). In specimens from PCa and BPH patients, the f-PSA to total PSA ratio (f/t) was found to range from 1% to higher than 60%. While maintaining an 80% sensitivity for cancer, the f/t ratio improved specificity to approximately 80%, as compared to 55% for total PSA alone. The receiver operating characteristics (ROC) curve analysis of the f/t ratio displayed a greater area under the plot (0.84) compared to total PSA alone (0.745). The results demonstrate that the f/t ratio significantly increases specificity for PCa detection compared to total PSA alone, showing the potential clinical value of the f-PSA immunoassay.

摘要

前列腺特异性抗原(PSA)是早期检测和监测前列腺癌(PCa)患者最重要的肿瘤标志物。许多良性前列腺增生(BPH)患者的PSA水平也会升高。对血清PSA形式,即游离PSA(f-PSA)和与α1-抗糜蛋白酶结合的PSA(PSA-ACT)的研究,可能会提高PCa和BPH之间的鉴别能力。据报道,一种对f-PSA特异的免疫测定法对PSA-ACT的交叉反应性非常低(0.7%)。对PSA水平在<1至>100 ng/ml之间的BPH和PCa患者(经活检确定)的血清标本进行了检测。正常女性(N = 50)的血清标本中未检测到f-PSA。健康男性(N = 60)的标本中检测到低水平(0 - 0.3 ng/ml)。在PCa和BPH患者的标本中,发现f-PSA与总PSA的比值(f/t)范围为1%至高于60%。在保持对癌症80%敏感性的同时,f/t比值将特异性提高到了约80%,而单独总PSA的特异性为55%。与单独总PSA(0.745)相比,f/t比值的受试者工作特征(ROC)曲线分析显示曲线下面积更大(0.84)。结果表明,与单独总PSA相比,f/t比值显著提高了PCa检测的特异性,显示了f-PSA免疫测定法的潜在临床价值。

相似文献

1
Dual monoclonal antibody immunoassay for free prostate-specific antigen.游离前列腺特异性抗原的双单克隆抗体免疫测定法。
Prostate. 1996 Jan;28(1):10-6. doi: 10.1002/(SICI)1097-0045(199601)28:1<10::AID-PROS2>3.0.CO;2-S.
2
The importance of human glandular kallikrein and its correlation with different prostate specific antigen serum forms in the detection of prostate carcinoma.人腺体激肽释放酶的重要性及其在前列腺癌检测中与不同前列腺特异性抗原血清形式的相关性。
Cancer. 1998 Dec 15;83(12):2540-7.
3
Discrimination of men with prostate cancer from those with benign disease by measurements of human glandular kallikrein 2 (HK2) in serum.通过检测血清中人腺激肽释放酶2(HK2)来鉴别前列腺癌男性与良性疾病男性。
J Urol. 2000 Jan;163(1):311-6.
4
A multicenter clinical trial on the use of alpha1-antichymotrypsin-prostate-specific antigen in prostate cancer diagnosis.一项关于使用α1-抗糜蛋白酶-前列腺特异性抗原进行前列腺癌诊断的多中心临床试验。
Prostate. 2001 May 1;47(2):77-84. doi: 10.1002/pros.1049.
5
Generation of PSA-ACT-specific monoclonal antibodies and their application in a sandwich immunoassay.前列腺特异性抗原-雄激素切割产物(PSA-ACT)特异性单克隆抗体的产生及其在夹心免疫测定中的应用。
Hybridoma. 1999 Dec;18(6):535-41. doi: 10.1089/hyb.1999.18.535.
6
Free to total prostate-specific antigen (PSA) ratio is superior to total-PSA in differentiating benign prostate hypertrophy from prostate cancer.游离前列腺特异性抗原(PSA)与总PSA的比值在区分良性前列腺增生和前列腺癌方面优于总PSA。
Prostate Suppl. 1996;7:30-4.
7
Review on the simultaneous determination of total prostate-specific antigen and free prostate-specific antigen.总前列腺特异性抗原和游离前列腺特异性抗原同步测定的综述
Prostate Suppl. 1996;7:48-57.
8
Ratio of alpha 1-antichymotrypsin--prostate specific antigen to total prostate specific antigen in prostate cancer diagnosis.α1-抗糜蛋白酶与前列腺特异性抗原的比值在前列腺癌诊断中与总前列腺特异性抗原的关系
Anticancer Res. 2000 Nov-Dec;20(6D):4997-5001.
9
Characterization and determination of the complex between prostate-specific antigen and alpha 1-protease inhibitor in benign and malignant prostatic diseases.良性和恶性前列腺疾病中前列腺特异性抗原与α1-蛋白酶抑制剂复合物的表征与测定
Scand J Clin Lab Invest Suppl. 2000;233:51-8.
10
The influence of prostate volume on the ratio of free to total prostate specific antigen in serum of patients with prostate carcinoma and benign prostate hyperplasia.前列腺体积对前列腺癌和良性前列腺增生患者血清中游离前列腺特异性抗原与总前列腺特异性抗原比值的影响。
Cancer. 1997 Jan 1;79(1):104-9.

引用本文的文献

1
Using the free-to-total prostate-specific antigen ratio to detect prostate cancer in men with nonspecific elevations of prostate-specific antigen levels.利用游离前列腺特异性抗原与总前列腺特异性抗原的比值,在前列腺特异性抗原水平非特异性升高的男性中检测前列腺癌。
J Gen Intern Med. 2000 Oct;15(10):739-48. doi: 10.1046/j.1525-1497.2000.90907.x.